Jing Chen1, Matthew J Budoff2, Muredach P Reilly3, Wei Yang4, Sylvia E Rosas5, Mahboob Rahman6, Xiaoming Zhang4, Jason A Roy4, Eva Lustigova7, Lisa Nessel4, Virginia Ford8, Dominic Raj9, Anna C Porter10, Elsayed Z Soliman11, Jackson T Wright6, Myles Wolf12, Jiang He1. 1. Department of Medicine, School of Medicine, Tulane University, New Orleans, Louisiana2Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana. 2. LA BioMed at Harbor-UCLA Medical Center, Los Angeles, California. 3. Department of Medicine, Division of Cardiology, Columbia University, New York, New York. 4. Department of Biostatistics and Epidemiology, School of Medicine, University of Pennsylvania, Philadelphia. 5. Joslyn Diabetic Center, Harvard Medical School, Boston, Massachusetts. 6. Department of Medicine, University Hospitals of Case Western Reserve University, Cleveland, Ohio. 7. Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana. 8. Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia. 9. Department of Medicine, School of Medicine, George Washington University, Washington, DC. 10. Department of Medicine, University of Illinois Hospital and Health Sciences System, Chicago. 11. Department of Medicine, School of Medicine, Wake Forest University, Winston-Salem, North Carolina. 12. Department of Medicine, School of Medicine, Duke University, Durham, North Carolina.
Abstract
Importance: Coronary artery calcification (CAC) is highly prevalent in dialysis-naive patients with chronic kidney disease (CKD). However, there are sparse data on the association of CAC with subsequent risk of cardiovascular disease and all-cause mortality in this population. Objective: To study the prospective association of CAC with risk of cardiovascular disease and all-cause mortality among dialysis-naive patients with CKD. Design, Setting, and Participants: The prospective Chronic Renal Insufficiency Cohort study recruited adults with an estimated glomerular filtration rate of 20 to 70 mL/min/1.73 m2 from 7 clinical centers in the United States. There were 1541 participants without cardiovascular disease at baseline who had CAC scores. Exposures: Coronary artery calcification was assessed using electron-beam or multidetector computed tomography. Main Outcomes and Measures: Incidence of cardiovascular disease (including myocardial infarction, heart failure, and stroke) and all-cause mortality were reported every 6 months and confirmed by medical record adjudication. Results: During an average follow-up of 5.9 years in 1541 participants aged 21 to 74 years, there were 188 cardiovascular disease events (60 cases of myocardial infarction, 120 heart failures, and 27 strokes; patients may have had >1 event) and 137 all-cause deaths. In Cox proportional hazards models adjusted for age, sex, race, clinical site, education level, physical activity, total cholesterol level, high-density lipoprotein cholesterol level, systolic blood pressure, use of antihypertensive treatment, current cigarette smoking, diabetes status, body mass index, C-reactive protein level, hemoglobin A1c level, phosphorus level, troponin T level, log N-terminal pro-B-type natriuretic peptide level, fibroblast growth factor 23 level, estimated glomerular filtration rate, and proteinuria, the hazard ratios associated with per 1 SD log of CAC were 1.40 (95% CI, 1.16-1.69; P < .001) for cardiovascular disease, 1.44 (95% CI, 1.02-2.02; P = .04) for myocardial infarction, 1.39 (95% CI, 1.10-1.76; P = .006) for heart failure, and 1.19 (95% CI, 0.94-1.51; P = .15) for all-cause mortality. In addition, inclusion of CAC score led to an increase in the C statistic of 0.02 (95% CI, 0-0.09; P < .001) for predicting cardiovascular disease over use of all the above-mentioned established and novel cardiovascular disease risk factors. Conclusions and Relevance: Coronary artery calcification is independently and significantly related to the risks of cardiovascular disease, myocardial infarction, and heart failure in patients with CKD. In addition, CAC improves risk prediction for cardiovascular disease, myocardial infarction, and heart failure over use of established and novel cardiovascular disease risk factors among patients with CKD; however, the changes in the C statistic are small.
Importance: Coronary artery calcification (CAC) is highly prevalent in dialysis-naive patients with chronic kidney disease (CKD). However, there are sparse data on the association of CAC with subsequent risk of cardiovascular disease and all-cause mortality in this population. Objective: To study the prospective association of CAC with risk of cardiovascular disease and all-cause mortality among dialysis-naive patients with CKD. Design, Setting, and Participants: The prospective Chronic Renal Insufficiency Cohort study recruited adults with an estimated glomerular filtration rate of 20 to 70 mL/min/1.73 m2 from 7 clinical centers in the United States. There were 1541 participants without cardiovascular disease at baseline who had CAC scores. Exposures: Coronary artery calcification was assessed using electron-beam or multidetector computed tomography. Main Outcomes and Measures: Incidence of cardiovascular disease (including myocardial infarction, heart failure, and stroke) and all-cause mortality were reported every 6 months and confirmed by medical record adjudication. Results: During an average follow-up of 5.9 years in 1541 participants aged 21 to 74 years, there were 188 cardiovascular disease events (60 cases of myocardial infarction, 120 heart failures, and 27 strokes; patients may have had >1 event) and 137 all-cause deaths. In Cox proportional hazards models adjusted for age, sex, race, clinical site, education level, physical activity, total cholesterol level, high-density lipoprotein cholesterol level, systolic blood pressure, use of antihypertensive treatment, current cigarette smoking, diabetes status, body mass index, C-reactive protein level, hemoglobin A1c level, phosphorus level, troponin T level, log N-terminal pro-B-type natriuretic peptide level, fibroblast growth factor 23 level, estimated glomerular filtration rate, and proteinuria, the hazard ratios associated with per 1 SD log of CAC were 1.40 (95% CI, 1.16-1.69; P < .001) for cardiovascular disease, 1.44 (95% CI, 1.02-2.02; P = .04) for myocardial infarction, 1.39 (95% CI, 1.10-1.76; P = .006) for heart failure, and 1.19 (95% CI, 0.94-1.51; P = .15) for all-cause mortality. In addition, inclusion of CAC score led to an increase in the C statistic of 0.02 (95% CI, 0-0.09; P < .001) for predicting cardiovascular disease over use of all the above-mentioned established and novel cardiovascular disease risk factors. Conclusions and Relevance: Coronary artery calcification is independently and significantly related to the risks of cardiovascular disease, myocardial infarction, and heart failure in patients with CKD. In addition, CAC improves risk prediction for cardiovascular disease, myocardial infarction, and heart failure over use of established and novel cardiovascular disease risk factors among patients with CKD; however, the changes in the C statistic are small.
Authors: Kunihiro Matsushita; Yingying Sang; Shoshana H Ballew; Michael Shlipak; Ronit Katz; Sylvia E Rosas; Carmen A Peralta; Mark Woodward; Holly J Kramer; David R Jacobs; Mark J Sarnak; Josef Coresh Journal: J Am Soc Nephrol Date: 2014-08-21 Impact factor: 10.121
Authors: Tamar S Polonsky; Robyn L McClelland; Neal W Jorgensen; Diane E Bild; Gregory L Burke; Alan D Guerci; Philip Greenland Journal: JAMA Date: 2010-04-28 Impact factor: 56.272
Authors: Amanda Hyre Anderson; Wei Yang; Chi-yuan Hsu; Marshall M Joffe; Mary B Leonard; Dawei Xie; Jing Chen; Tom Greene; Bernard G Jaar; Patricia Kao; John W Kusek; J Richard Landis; James P Lash; Raymond R Townsend; Matthew R Weir; Harold I Feldman Journal: Am J Kidney Dis Date: 2012-06-02 Impact factor: 8.860
Authors: Brenda R Hemmelgarn; Braden J Manns; Anita Lloyd; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Marcello Tonelli Journal: JAMA Date: 2010-02-03 Impact factor: 56.272
Authors: Bryan R Kestenbaum; Kathryn L Adeney; Ian H de Boer; Joachim H Ix; Michael G Shlipak; David S Siscovick Journal: Kidney Int Date: 2009-08-19 Impact factor: 10.612
Authors: Jiang He; Muredach Reilly; Wei Yang; Jing Chen; Alan S Go; James P Lash; Mahboob Rahman; Chris DeFilippi; Crystal Gadegbeku; Radhika Kanthety; Kaixiang Tao; L Lee Hamm; Akinlolu Ojo; Ray Townsend; Matthew Budoff Journal: Am J Cardiol Date: 2012-09-14 Impact factor: 2.778
Authors: Ron T Gansevoort; Ricardo Correa-Rotter; Brenda R Hemmelgarn; Tazeen H Jafar; Hiddo J Lambers Heerspink; Johannes F Mann; Kunihiro Matsushita; Chi Pang Wen Journal: Lancet Date: 2013-05-31 Impact factor: 79.321
Authors: Joshua D Bundy; Xuan Cai; Julia J Scialla; Mirela A Dobre; Jing Chen; Chi-Yuan Hsu; Mary B Leonard; Alan S Go; Panduranga S Rao; James P Lash; Raymond R Townsend; Harold I Feldman; Ian H de Boer; Geoffrey A Block; Myles Wolf; Edward R Smith; Andreas Pasch; Tamara Isakova Journal: Am J Kidney Dis Date: 2019-03-29 Impact factor: 8.860
Authors: Chan-Young Jung; Ga Young Heo; Jung Tak Park; Young Su Joo; Hyung Woo Kim; Hyunsun Lim; Tae Ik Chang; Ea Wha Kang; Tae-Hyun Yoo; Shin-Wook Kang; Joongyub Lee; Soo Wan Kim; Yun Kyu Oh; Ji Yong Jung; Kook-Hwan Oh; Curie Ahn; Seung Hyeok Han Journal: Clin Res Cardiol Date: 2021-05-18 Impact factor: 5.460
Authors: Joshua D Bundy; Jing Chen; Wei Yang; Matthew Budoff; Alan S Go; Juan E Grunwald; Radhakrishna R Kallem; Wendy S Post; Muredach P Reilly; Ana C Ricardo; Sylvia E Rosas; Xiaoming Zhang; Jiang He Journal: Atherosclerosis Date: 2018-02-10 Impact factor: 5.162
Authors: Joshua D Bundy; Xuan Cai; Rupal C Mehta; Julia J Scialla; Ian H de Boer; Chi-Yuan Hsu; Alan S Go; Mirela A Dobre; Jing Chen; Panduranga S Rao; Mary B Leonard; James P Lash; Geoffrey A Block; Raymond R Townsend; Harold I Feldman; Edward R Smith; Andreas Pasch; Tamara Isakova Journal: Clin J Am Soc Nephrol Date: 2019-10-28 Impact factor: 8.237